ArticleRespiratory medicine case reports2021

A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation.

Tomoyo Oguri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.